Skip navigation.
Thu Mar 18 13:28:17 2010 [Write for us] | [Login/Register]
Home

Mead Johnson Nutrition

by Brian Orelli - November 18, 2009 - 0 comments

After seeing shares of its spinoff Mead Johnson Nutrition (NYSE: MJN) nearly double since its IPO in February, Bristol-Myers Squibb (NYSE: BMY) has decided now's the time to sell the 83% of the baby formula producer that it still owns.

Recent comments

User login